Canada markets open in 6 hours 32 minutes

Numinus Wellness Inc. (NUMI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.7000-0.0300 (-4.11%)
At close: 3:59PM EDT
Full screen
Previous Close0.7300
Open0.7300
Bid0.7000 x N/A
Ask0.7200 x N/A
Day's Range0.7000 - 0.7300
52 Week Range0.4050 - 2.4500
Volume262,671
Avg. Volume369,073
Market Cap140.751M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1040
Earnings DateApr. 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.10
  • Baystreet

    Stocks in play: Numinus Wellness Inc.

    Has finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin ...

  • CNW Group

    Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

    Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin extract, previously announced on April 26, 2021. This major milestone advances Numinus' investigation of its first proprietary psychedelic product, which was developed using a patent-pending technology submitted to the US Patent and Trade Office.

  • CNW Group

    KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

    Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.